Hussein Al-Mossawi

Has grant

NIHR Academic Clinical Lecturer

University of Oxford
Country flagUnited Kingdom
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

The role GM-CSF producing lymphocytes in Psoriatic Arthritis

Open Date: 2016-08-01

Close Date: 2019-07-01

Articles (2)

Tissue-targeted immunotherapies for type 1 diabetes (T1D) hold potential to protect pancreatic beta cells while minimizing systemic immunosuppression. We used a bispecific agonist called Immune Modulating Monoclonal-TCR Against Autoimmune Disease (ImmTAAI), consisting of a T cell receptor (TCR) targeting domain fused with a PD-1 agonist to specifically bind beta cells and suppress autoreactive T cells. We used live pancreas slices to demonstrate targeting of ImmTAAI molecules to pre-proinsulin peptide-HLA-A2 complexes on human beta cells. ImmTAAI protected beta cells from T cell killing by increasing T cell motility and inhibiting cytokine secretion. ImmTAAI treatment also increased the motility of islet-infiltrating T cells in slices from a donor with recent-onset T1D and preserved insulin secretion in slices co-cultured with T cell avatars transduced with diabetogenic TCRs. These data demonstrate that ImmTAAI molecules have the potential to limit T cell activity locally, making this an attractive platform to elicit targeted immunoregulation in T1D. One Sentence Summary We demonstrate inhibition of cellular immunity in human type 1 diabetes using a beta cell-targeting, affinity-enhanced TCR fused to a PD-1 agonist.

Year:

2025

Insights into variation in monocyte context-specific splicing and transcript usage are limited. We have performed paired gene and transcript QTL mapping across distinct immune states using RNA-seq of monocytes isolated from a cohort of 185 healthy Europeans incubated alone or in the presence of IFNγ or lipopolysaccharide (LPS). We identify regulatory variants to 5,749 genes and 8,727 transcripts, with 291 context-specific tQTL colocalising with GWAS loci (PP.H4 > 0.8). Notable disease relevant associations (PP.H4 > 0.99) include IFNγ specific tQTL at COVID-19 severity locus rs10735079, where allelic variation modulates context-specific splicing of OAS1 , and at rs4072037, a risk allele for gastro-esophageal cancer, which associates with context-specific splicing of MUC1 . Assessment of DNA methylation from the same cells demonstrated frequent overlap between mQTL and causal context-specific eQTL, frequently permitting inference of the direction of effect. Finally, we identify a subset of eQTL that uncouple genes from proximally acting regulatory networks, creating ‘co-expression QTL’ (coExQTL) with differential allele-specific correlation networks. Our findings highlight the interplay between context and genetics in the regulation of the monocyte gene expression and splicing, revealing putative mechanisms of diverse disease risk alleles including for COVID-19 and cancer.

Year:

2024

Collaborators (8)

Mark A. Atkinson

University of Florida

UNITED STATES
View details

Orion Tong

Garvan Institute of Medical Research

AUSTRALIA
View details

Todd Brusko

Professor/Scientific Director

University of Florida

UNITED STATES
View details

Edward Phelps

Associate Professor

University of Florida

UNITED STATES
View details

Julian Knight

University of Oxford

UNITED KINGDOM
View details

James J Gilchrist

University of Oxford

UNITED KINGDOM
View details

Benjamin Fairfax

Principal Investigator

University of Oxford

UNITED KINGDOM
View details

Holger A. Russ

University of Colorado Anschutz Medical Campus

UNITED STATES
View details